Anđela Horvat

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Basal Cell Carcinoma

Cognitive Decline

Top Venues

International journal of molecular sciences

Life (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Bastien Proust, Anđela Horvat, Ana Dekanić, Ignacija Vlašić, Maja Herak Bosnar
Mitochondrial NME6 Influences Basic Cellular Processes in Tumor Cells In Vitro. International journal of molecular sciences 25 (17) (2024)
Anđela Horvat, Ignacija Vlašić, Jasminka Štefulj, Nada Oršolić, Maja Jazvinšćak Jembrek
Flavonols as a Potential Pharmacological Intervention for Alleviating Cognitive Decline in Diabetes: Evidence from Preclinical Studies. Life (Basel, Switzerland) 13 (12) (2023)
Anđela Horvat, Ignacija Vlašić, Jasminka Štefulj, Nada Oršolić, Maja Jazvinšćak Jembrek
Flavonols as a Potential Pharmacological Intervention for Alleviating Cognitive Decline in Diabetes: Evidence from Preclinical Studies. Life (Basel, Switzerland) 13 (12) (2023)
Ignacija Vlašić, Anđela Horvat, Ana Dekanić, Neda Slade
p53 Family in Resistance to Targeted Therapy of Melanoma. International journal of molecular sciences 24 (1) (2022)
Martina Radić, Ignacija Vlašić, Maja Jazvinšćak Jembrek, Anđela Horvat, Ana Dekanić, Maja Sabol, Marko Dužević, Maja Herak Bosnar, Neda Slade
Characterization of Vemurafenib-Resistant Melanoma Cell Lines Reveals Novel Hallmarks of Targeted Therapy Resistance. International journal of molecular sciences 23 (17) (2022)
Ignacija Vlašić, Anđela Horvat, Ana Dekanić, Neda Slade
p53 Family in Resistance to Targeted Therapy of Melanoma. International journal of molecular sciences 24 (1) (2022)
Ignacija Vlašić, Anđela Horvat, Ana Dekanić, Neda Slade
p53 Family in Resistance to Targeted Therapy of Melanoma. International journal of molecular sciences 24 (1) (2022)